In May of that year, Pfizer signed an expanded licensing deal with Aurobindo to acquire the rights to 55 solid oral dose products and five sterile injectable products for patients in more than 70 emerging market countries.
The SEC has charged former Sangamo BioSciences executive Winson Tang with insider trading. Tang is accused of telling a friend about a 2014 agreement between Sangamo and Biogen before the news became public.
A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical firm Innate Immunotherapeutics, a company for which he serves as a board member.